论文部分内容阅读
目的:评价36例急性ST段抬高性心肌梗死溶栓治疗的临床疗效,寻求降低病死率,改善预后的措施。方法:收治急性ST段抬高性心肌梗死患者36例,观察运用溶栓方法治疗的临床效果。结果:溶栓治疗36例(100%),其中男31例(86.1%),女5例(13.9%),≤65岁27例(75%)。溶栓距发病时间240±90分钟,溶栓后岀血5例(13.8%),与国内大型溶栓试验(11.1%与15.1%)相比,岀血发病率未见明显升高(P>0.05),未见危及生命的岀血?崧郏?溶栓治疗具有快速、简便、经济、易操作的特点,对STEMI的患者仍然是减少病死率及改善预后的重要方法。
Objective: To evaluate the clinical efficacy of thrombolytic therapy in 36 patients with acute ST-segment elevation myocardial infarction (MI) and find ways to reduce mortality and improve prognosis. Methods: Thirty-six patients with acute ST-elevation myocardial infarction were enrolled in this study. The clinical effect of thrombolytic therapy was observed. Results Thrombolytic therapy in 36 cases (100%), including 31 males (86.1%), 5 females (13.9%), 27 patients (65%) ≤ 65 years. The onset time of thrombolysis was 240 ± 90 minutes, and 5 cases (13.8%) of thrombolysis after thrombolysis. Compared with the large-scale thrombolysis test in China (11.1% vs 15.1%), the incidence of blood was no significant increase (P> 0.05), and no life-threatening nocturnal bleeding was found. Song-thrombolytic therapy was a rapid, simple, economical and easy-to-use procedure. It is still an important method to reduce mortality and improve prognosis in patients with STEMI.